Do Caregivers Feel Supported in Administering Cannabis in Dementia Care?
Administering medication in dementia care can be challenging, especially when treatments involve unlicensed or unfamiliar products such as cannabis-based medicinal products (CBPMs). While some caregivers report improved calmness and easier symptom management, others say they lack guidance on safe dosing, side effect recognition, and record-keeping. According to NHS England and NICE guideline NG144, CBPMs are only licensed for […]
Are There Shared Tips for Dosing Schedules of Cannabis in Dementia Care?
When medical cannabis is considered for dementia-related symptoms such as agitation or sleep disturbance, dosing schedules become a key safety factor. Older adults are more sensitive to psychoactive effects and often take multiple medications, making titration a cautious process. Clinicians emphasise that while some families share anecdotal routines online, only specialists on the GMC register can prescribe cannabis-based medicinal products […]
Do Caregivers Notice Improved Mood and Social Engagement in Dementia Patients with Cannabis Use?
As dementia progresses, emotional withdrawal and social isolation often become as distressing as memory loss. Families frequently describe their loved ones as “present but distant.” Traditional medications for agitation or depression can sometimes worsen apathy or confusion. This has led caregivers to ask whether cannabis-based medicinal products (CBPMs) might help restore a sense of calm or connection. […]
Have Fall Incidents Decreased in Dementia After Cannabis Initiation?
Falls are one of the most serious risks for people living with dementia, often leading to injury, hospitalisation, and loss of independence. According to NHS England and NICE guidance NG144, cannabis-based medicines remain unlicensed for dementia. Both organisations caution that dizziness, somnolence, and balance instability are recognised side effects in older adults. The MHRA also requires prescribers to record fall history and mobility assessments before starting CBPMs under the Human Medicines […]
Are Meals Improved with Cannabis Use in Dementia Patients?
Loss of appetite and unintentional weight loss are common in dementia, particularly as the condition progresses. These changes can result from reduced smell or taste, swallowing difficulties, medication effects, or mood changes. Families often describe mealtimes as stressful or disorganised, with patients refusing food or forgetting to eat. Given cannabis’s known effects on appetite in […]
Do Families Report Fewer Behavioural Outbreaks in Dementia Patients After Cannabis Use?
Aggression, agitation, and sudden behavioural outbursts are among the most difficult symptoms of dementia, often leading to distress and carer burnout. Conventional medicines such as antipsychotics can carry serious side effects, including sedation and stroke risk, prompting some families to ask whether medical cannabis could offer a calmer alternative. Although the interest is growing, NICE guidance […]
Are Dementia Patients Sleeping Better with Cannabis?
Sleep disturbance is one of the most common and distressing symptoms in dementia, affecting both patients and their caregivers. From nighttime wandering to agitation and reversed sleep patterns, poor rest can worsen confusion and caregiver stress. In recent years, researchers and families have started asking whether medical cannabis might help improve sleep quality, but evidence remains early and inconsistent. […]
What Have Caregivers Noticed About Cannabis Calming Dementia?
As dementia progresses, behavioural symptoms such as agitation, anxiety, and sleep disturbance can be distressing for both patients and caregivers. Traditional medications, including antipsychotics and sedatives, can cause serious side effects, leading some families to explore whether cannabis-based medicines might offer a gentler alternative. Although no cannabis-based products for medicinal use (CBPMs) are currently licensed for dementia in the […]
Are There National Guidelines for Cannabis Prescribing in Dementia?
In the UK, there are currently no national guidelines approving medical cannabis for dementia symptoms such as agitation, anxiety, or sleep disturbance. According to NICE guidance NG144, cannabis-based medicinal products (CBPMs) should only be prescribed by specialist clinicians for a limited number of conditions, specifically, severe epilepsy, chemotherapy-induced nausea, and spasticity associated with multiple sclerosis. Dementia is not […]
Is Telehealth Used for Cannabis Assessment in Dementia?
According to NHS England (2023), only specialists on the GMC Specialist Register can prescribe cannabis-based products for medicinal use (CBPMs), including through video consultations, provided they hold full access to the patient’s records. Dementia is not an approved indication under current NHS policy, and remote assessment must still meet the same clinical and governance standards as in-person […]